Stirlingshire Investments’s Counterpoint Quantitative Equity ETF CPAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$488K Sell
11,673
-1,750
-13% -$75.5K 0.43% 60
2025
Q4
$538K Buy
+13,423
New +$532K 0.48% 57

Other funds holding CPAI

Stirlingshire Investments's CPAI Position: Q1 2026 in Review

Stirlingshire Investments reduced its Counterpoint Quantitative Equity ETF (CPAI) stake by 13% in Q1 2026, selling an estimated $75.5K and leaving 11,673 shares worth $488K. The position accounts for 0.43% of the portfolio, ranked #60.

Stirlingshire Investments first reported a position in CPAI in Q4 2025 and has held it in 2 quarters since. The position peaked at $538K in Q4 2025. 33 funds tracked by Wall St. Rank hold CPAI as of Q1 2026.

  • Stirlingshire Investments held 11,673 shares of Counterpoint Quantitative Equity ETF worth $488K as of Q1 2026.
  • Stirlingshire Investments sold 1,750 Counterpoint Quantitative Equity ETF shares in Q1 2026, an estimated $75.5K.
  • Counterpoint Quantitative Equity ETF made up 0.43% of Stirlingshire Investments's portfolio in Q1 2026, its #60 holding.
  • Stirlingshire Investments first reported a position in Counterpoint Quantitative Equity ETF in Q4 2025 and has held it in 2 quarters since.
  • Stirlingshire Investments's Counterpoint Quantitative Equity ETF position peaked at $538K in Q4 2025.
  • 33 funds tracked by Wall St. Rank held Counterpoint Quantitative Equity ETF as of Q1 2026.

Based on Stirlingshire Investments's 13F filing for Q1 2026, filed 4 May 2026.